Q3 2017 Holdings
Filed 2017-11-13 | 145 holdings | $11.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pfizer Inc.(PFE) | Common | 717081103 | $34.9K | 978,676 | 0.3% |
| Ligand Pharmaceuticals Incorporated(LGND) | Common | 53220K504 | $108.7K | 798,100 | 1.0% |
| AxoGen, Inc.(AXGN) | Common | 05463X106 | $366.0K | 18,898 | 3.3% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $458.0K | 34,320 | 4.1% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | Common | 14888U101 | $920.0K | 365,110 | 8.2% |
| CoreCivic, Inc.(CXW) | Common | 21871N101 | $2.0M | 75,000 | 18.0% |
| Ambac Financial Group, Inc.(OSG) | Common | 023139884 | $2.5M | 145,426 | 22.5% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $4.7M | 52,500 | 41.8% |